PRIMARY IMMUNE REGULATORY DISORDER
Clinical trials for PRIMARY IMMUNE REGULATORY DISORDER explained in plain language.
Never miss a new study
Get alerted when new PRIMARY IMMUNE REGULATORY DISORDER trials appear
Sign up with your email to follow new studies for PRIMARY IMMUNE REGULATORY DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a stem cell transplant tame severe immune disorders?
Disease control Recruiting nowThis study tests a stem cell transplant for people aged 5 to 40 with severe immune disorders like common variable immunodeficiency (CVID) or other conditions that cause the immune system to attack the body. The goal is to replace the faulty immune system with a healthy donor's st…
Matched conditions: PRIMARY IMMUNE REGULATORY DISORDER
Phase: PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated May 17, 2026 00:44 UTC
-
Immune cell boost may shield kids from Post-Transplant infections
Disease control Recruiting nowThis study tests whether adding a special type of immune cell (memory T cells) after a donor stem cell transplant can help prevent serious viral and fungal infections. It involves up to 100 children and young adults with blood cancers or immune disorders. The approach aims to spe…
Matched conditions: PRIMARY IMMUNE REGULATORY DISORDER
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New approach aims to tame inflammation before Life-Saving transplant
Disease control Recruiting nowThis study is testing two different drug treatments to see if they can reduce harmful inflammation in people with severe immune system disorders, making them better prepared to receive a stem cell transplant. Researchers want to know if these treatments help the donated stem cell…
Matched conditions: PRIMARY IMMUNE REGULATORY DISORDER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 20, 2026 16:15 UTC